Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1967 Jan;46(1):103–110. doi: 10.1172/JCI105503

Human Placental Lactogen: Studies of Its Acute Metabolic Effects and Disposition in Normal Man*

Paul Beck 1,†, William H Daughaday 1,‡
PMCID: PMC297025  PMID: 6018742

Abstract

The acute metabolic effects and disposition of human placental lactogen (HPL) have been studied in 15 men and 8 women during continuous intravenous infusions. The mean plasma half-life, metabolic pool size, and turnover rate of HPL are comparable to the values previously reported for human growth hormone (HGH). From the data presented, we calculate that the placenta secretes approximately 290 mg HPL daily at term.

After 12-hour infusions of HPL in physiologic amounts, impairment of glucose tolerance despite increased plasma insulin responses to glucose was observed in 7 of 8 subjects tested. However, HPL, unlike HGH, did not produce significant changes in blood glucose, plasma insulin, or plasma free fatty acid concentrations in fasting subjects before glucose administration or in carbohydrate tolerance or plasma insulin responses to glucose during 5-hour infusions. These findings are compatible with the thesis that HPL is a physiologic antagonist to insulin during pregnancy.

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLEICHER S. J., O'SULLIVAN J. B., FREINKEL N. CARBOHYDRATE METABOLISM IN PREGNANCY. V. THE INTERRELATIONS OF GLUCOSE, INSULIN AND FREE FATTY ACIDS IN LATE PREGNANCY AND POST PARTUM. N Engl J Med. 1964 Oct 22;271:866–872. doi: 10.1056/NEJM196410222711702. [DOI] [PubMed] [Google Scholar]
  2. BURT R. L. Peripheral utilization of glucose in pregnancy. III. Insulin tolerance. Obstet Gynecol. 1956 Jun;7(6):658–664. [PubMed] [Google Scholar]
  3. Beck P., Parker M. L., Daughaday W. H. Radioimmunologic measurement of human placental lactogen in plasma by a double antibody method during normal and diabetic pregnancies. J Clin Endocrinol Metab. 1965 Nov;25(11):1457–1462. doi: 10.1210/jcem-25-11-1457. [DOI] [PubMed] [Google Scholar]
  4. Beck P., Schalch D. S., Parker M. L., Kipnis D. M., Daughaday W. H. Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly. J Lab Clin Med. 1965 Sep;66(3):366–379. [PubMed] [Google Scholar]
  5. COHEN H., GRUMBACH M. M., KAPLAN S. L. PREPARATION OF HUMAN CHORIONIC "GROWTH HORMONE-PROLACTIN". Proc Soc Exp Biol Med. 1964 Nov;117:438–441. doi: 10.3181/00379727-117-29602. [DOI] [PubMed] [Google Scholar]
  6. DE MOOR P., STEENO O., RASKIN M., HENDRIKX A. Fluorimetric determination of free plasma 11-hydroxycorticosteroids in man. Acta Endocrinol (Copenh) 1960 Feb;33:297–307. doi: 10.1530/acta.0.xxxiii0297. [DOI] [PubMed] [Google Scholar]
  7. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duncombe W. G. The colorimetric micro-determination of long-chain fatty acids. Biochem J. 1963 Jul;88(1):7–10. doi: 10.1042/bj0880007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FRASER R., JOPLIN G. F., OPIE L. H., RABINOWITZ D. The augmented insulin tolerance test for detecting insulin resistance. J Endocrinol. 1962 Dec;25:299–307. doi: 10.1677/joe.0.0250299. [DOI] [PubMed] [Google Scholar]
  10. FRIESEN H. PURIFICATION OF A PLACENTAL FACTOR WITH IMMUNOLOGICAL AND CHEMICAL SIMILARITY TO HUMAN GROWTH HORMONE. Endocrinology. 1965 Mar;76:369–381. doi: 10.1210/endo-76-3-369. [DOI] [PubMed] [Google Scholar]
  11. GERSHBERG H., JAVIER Z., HULSE M. GLUCOSE TOLERANCE IN WOMEN RECEIVING AN OVULATORY SUPPRESSANT. Diabetes. 1964 Jul-Aug;13:378–382. doi: 10.2337/diab.13.4.378. [DOI] [PubMed] [Google Scholar]
  12. Grumbach M. M., Kaplan S. L., Abrams C. L., Bell J. J., Conte F. A. Plasma free fatty acid response to the administration of chorionic "growth hormone-prolactin". J Clin Endocrinol Metab. 1966 Apr;26(4):478–482. doi: 10.1210/jcem-26-4-478. [DOI] [PubMed] [Google Scholar]
  13. JOSIMOVICH J. B., BRANDE B. L. CHEMICAL PROPERTIES AND BIOLOGIC EFFECTS OF HUMAN PLACENTAL LACTOGEN (HPL). Trans N Y Acad Sci. 1964 Dec;27:161–166. doi: 10.1111/j.2164-0947.1964.tb02185.x. [DOI] [PubMed] [Google Scholar]
  14. JOSIMOVICH J. B., MACLAREN J. A. Presence in the human placenta and term serum of a highly lactogenic substance immunologically related to pituitary growth hormone. Endocrinology. 1962 Aug;71:209–220. doi: 10.1210/endo-71-2-209. [DOI] [PubMed] [Google Scholar]
  15. Josimovich J. B. Potentiation of somatotrophic and diabetogenic effects of growth hormone by human placental lactogen (HPL). Endocrinology. 1966 Apr;78(4):707–714. doi: 10.1210/endo-78-4-707. [DOI] [PubMed] [Google Scholar]
  16. KALKHOFF R., SCHALCH D. S., WALKER J. L., BECK P., KIPNIS D. M., DAUGHADAY W. H. DIABETOGENIC FACTORS ASSOCIATED WITH PREGNANCY. Trans Assoc Am Physicians. 1964;77:270–280. [PubMed] [Google Scholar]
  17. KAPLAN S. L., GRUMBACH M. M. IMMUNOASSAY FOR HUMAN CHORIONIC "GROWTH HORMONE-PROLACTIN" IN SERUM AND URINE. Science. 1965 Feb 12;147(3659):751–753. doi: 10.1126/science.147.3659.751. [DOI] [PubMed] [Google Scholar]
  18. Kaplan S. L., Grumbach M. M. Serum chorionic "growth hormone-prolactin" and serum pituitary growth hormone in mother and fetus at term. J Clin Endocrinol Metab. 1965 Oct;25(10):1370–1374. doi: 10.1210/jcem-25-10-1370. [DOI] [PubMed] [Google Scholar]
  19. LUFT R., CERASI E. EFFECT OF HUMAN GROWTH HORMONE ON INSULIN PRODUCTION IN PANHYPOPITUITARISM. Lancet. 1964 Jul 18;2(7351):124–126. doi: 10.1016/s0140-6736(64)90130-8. [DOI] [PubMed] [Google Scholar]
  20. PARKER M. L., UTIGER R. D., DAUGHADAY W. H. Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man. J Clin Invest. 1962 Feb;41:262–268. doi: 10.1172/JCI104479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. ROY E. J., MACKAY R. The concentration of oestrogens in blood during pregnancy. J Obstet Gynaecol Br Emp. 1962 Feb;69:13–17. doi: 10.1111/j.1471-0528.1962.tb00002.x. [DOI] [PubMed] [Google Scholar]
  22. SPELLACY W. N., GOETZ F. C., GREENBERG B. Z., ELLS J. PLASMA INSULIN IN NORMAL "EARLY" PREGNANCY. Obstet Gynecol. 1965 Jun;25:862–865. [PubMed] [Google Scholar]
  23. SPELLACY W. N., GOETZ F. C., GREENBERG B. Z., ELLS J. PLASMA INSULIN IN NORMAL MIDPREGNANCY. Am J Obstet Gynecol. 1965 May 1;92:11–15. doi: 10.1016/0002-9378(65)90099-2. [DOI] [PubMed] [Google Scholar]
  24. SPELLACY W. N., GOETZ F. C. Plasma insulin in normal late pregnancy. N Engl J Med. 1963 May 2;268:988–991. doi: 10.1056/NEJM196305022681805. [DOI] [PubMed] [Google Scholar]
  25. Spellacy W. N., Carlson K. L. Plasma insulin and blood glucose levels in patients taking oral contraceptives. A preliminary report of a prospective study. Am J Obstet Gynecol. 1966 Jun 15;95(4):474–478. doi: 10.1016/0002-9378(66)90137-2. [DOI] [PubMed] [Google Scholar]
  26. TAIT J. F., TAIT S. A., LITTLE B., LAUMAS K. R. The disappearance of 7-H-3-d-aldosterone in the plasma of normal subjects. J Clin Invest. 1961 Jan;40:72–80. doi: 10.1172/JCI104239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Turtle J. R., Beck P., Daughaday W. H. Purification of human placental lactogen. Endocrinology. 1966 Jul;79(1):187–190. doi: 10.1210/endo-79-1-187. [DOI] [PubMed] [Google Scholar]
  28. VAN MOLENH DETERMINATION OF PLASMA PROGESTERONE DURING PREGNANCY. Clin Chim Acta. 1963 Nov;8:943–953. doi: 10.1016/0009-8981(63)90019-6. [DOI] [PubMed] [Google Scholar]
  29. Worcester J. The statistical method. N Engl J Med. 1966 Jan 6;274(1):27–36. doi: 10.1056/NEJM196601062740106. [DOI] [PubMed] [Google Scholar]
  30. ZILVERSMIT D. B. The design and analysis of isotope experiments. Am J Med. 1960 Nov;29:832–848. doi: 10.1016/0002-9343(60)90117-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES